VANA / USDT

VANA / TRY

VANA / FDUSD

VANA / BNB

LAYER / BNB

WIF / EUR

ACH / USDT

ACH / TRY

PEOPLE / BTC

LAYER / TRY

LINA / USDT

COMBO / TRY

COMBO / USDT

SNT / USDT

FUN / USDT

SNT / ETH

CTXC / BTC

MAV / BTC

CTXC / USDT

ARPA / BTC

WOL 3D INDIA LIMITED

VIBHOR STEEL TUBES LTD

MANUGRAPH INDIA LIMITED

SANGINITA CHEMICALS LTD

RAJESH EXPORTS LTD

EURO PANEL PRODUCTS LTD

SML ISUZU LIMITED

SPECIALITY REST LTD

LIKHITHA INFRASTRUC LTD

STEEL EXCHANGE INDIA LTD

KEI INDUSTRIES LTD.

ROCKINGDEALS CIRCU ECO L

NEELAM LINENS & GAR (I) L

P S RAJ STEELS LIMITED

PRAXIS HOME RETAIL LTD

PRAMARA PROMOTIONS LTD

ADROIT INFOTECH LIMITED

KHANDWALA SECURITIES LTD

PREMIUM PLAST LIMITED

SHREE TIRUPATI BALAJEE L

Click here to get full coverage on Windlas Biotech Schedules Investor Meeting at Dehradun Facility - TipRanks

Windlas Biotech Schedules Investor Meeting at Dehradun Facility  TipRanks

Windlas Biotech Schedules Investor Meeting at Dehradun Facility - TipRanks

Click here to get full coverage on Windlas Biotech’s new injectable facility receives GMP certification - Indian Pharma Post

Windlas Biotech’s new injectable facility receives GMP certification  Indian Pharma Post

Windlas Biotech’s new injectable facility receives GMP certification - Indian Pharma Post

Click here to get full coverage on Windlas Biotech (NSE:WINDLAS) Seems To Use Debt Quite Sensibly - Simply Wall St

Windlas Biotech (NSE:WINDLAS) Seems To Use Debt Quite Sensibly  Simply Wall St

Windlas Biotech (NSE:WINDLAS) Seems To Use Debt Quite Sensibly - Simply Wall St

Click here to get full coverage on Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron - Medical Dialogues

Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron  Medical Dialogues

Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron - Medical Dialogues

Click here to get full coverage on Windlas Biotech's Stock Hits 52-Week High, Outperforms Sector and Sensex - MarketsMojo

Windlas Biotech's Stock Hits 52-Week High, Outperforms Sector and Sensex  MarketsMojo

Windlas Biotech's Stock Hits 52-Week High, Outperforms Sector and Sensex - MarketsMojo

Click here to get full coverage on Windlas Biotech Schedules Investor Meeting to Enhance Stakeholder Engagement - TipRanks

Windlas Biotech Schedules Investor Meeting to Enhance Stakeholder Engagement  TipRanks

Windlas Biotech Schedules Investor Meeting to Enhance Stakeholder Engagement - TipRanks

Click here to get full coverage on Small, midcap indices extend rise to 2nd day: Linde India, Windlas Biotech among top gainers - TradingView

Small, midcap indices extend rise to 2nd day: Linde India, Windlas Biotech among top gainers  TradingView

Small, midcap indices extend rise to 2nd day: Linde India, Windlas Biotech among top gainers - TradingView

Click here to get full coverage on Windlas Biotech - These 9 stocks surge 90-200% in a year despite continuous stake cuts by MFs - The Economic Times

Windlas Biotech - These 9 stocks surge 90-200% in a year despite continuous stake cuts by MFs  The Economic Times

Windlas Biotech - These 9 stocks surge 90-200% in a year despite continuous stake cuts by MFs - The Economic Times

Click here to get full coverage on Windlas Biotech gains after receiving GMP certification for new injectable facility - Business Standard

Windlas Biotech gains after receiving GMP certification for new injectable facility  Business Standard

Windlas Biotech gains after receiving GMP certification for new injectable facility - Business Standard

Click here to get full coverage on Windlas Biotech’s injectable facility gets GMP certification - BusinessLine

Windlas Biotech’s injectable facility gets GMP certification  BusinessLine

Windlas Biotech’s injectable facility gets GMP certification - BusinessLine

Click here to get full coverage on Windlas Biotech's Stock Reaches All-Time High, Outperforms Sector and Sensex - MarketsMojo

Windlas Biotech's Stock Reaches All-Time High, Outperforms Sector and Sensex  MarketsMojo

Windlas Biotech's Stock Reaches All-Time High, Outperforms Sector and Sensex - MarketsMojo

Click here to get full coverage on Has Windlas Biotech Limited's (NSE:WINDLAS) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Simply Wall St

Has Windlas Biotech Limited's (NSE:WINDLAS) Impressive Stock Performance Got Anything to Do With Its Fundamentals?  Simply Wall St

Has Windlas Biotech Limited's (NSE:WINDLAS) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Simply Wall St

Click here to get full coverage on Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility - Business Standard

Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility  Business Standard

Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility - Business Standard

Click here to get full coverage on Windlas Biotech Faces Significant Decline Amid Broader Market Challenges - MarketsMojo

Windlas Biotech Faces Significant Decline Amid Broader Market Challenges  MarketsMojo

Windlas Biotech Faces Significant Decline Amid Broader Market Challenges - MarketsMojo

Click here to get full coverage on What You Can Learn From Windlas Biotech Limited's (NSE:WINDLAS) P/E After Its 28% Share Price Crash - Simply Wall St

What You Can Learn From Windlas Biotech Limited's (NSE:WINDLAS) P/E After Its 28% Share Price Crash  Simply Wall St

What You Can Learn From Windlas Biotech Limited's (NSE:WINDLAS) P/E After Its 28% Share Price Crash - Simply Wall St

Click here to get full coverage on Windlas Biotech Reports Record Sales Amid Stable Financial Structure and Market Outperformance - MarketsMojo

Windlas Biotech Reports Record Sales Amid Stable Financial Structure and Market Outperformance  MarketsMojo

Windlas Biotech Reports Record Sales Amid Stable Financial Structure and Market Outperformance - MarketsMojo

Click here to get full coverage on Windlas Biotech's Stock Faces Decline, But Shows Potential for Growth in Pharmaceutical Industry - MarketsMojo

Windlas Biotech's Stock Faces Decline, But Shows Potential for Growth in Pharmaceutical Industry  MarketsMojo

Windlas Biotech's Stock Faces Decline, But Shows Potential for Growth in Pharmaceutical Industry - MarketsMojo

Click here to get full coverage on Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y - Moneycontrol

Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y  Moneycontrol

Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y - Moneycontrol

Click here to get full coverage on WINDLAS BIOTECH Share Price Today Up 6% - Equitymaster

WINDLAS BIOTECH Share Price Today Up 6%  Equitymaster

WINDLAS BIOTECH Share Price Today Up 6% - Equitymaster

Click here to get full coverage on Bisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol - Medical Dialogues

Bisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol  Medical Dialogues

Bisoprolol, Telmisartan, Chlorthalidone FDC: CDSCO asks Windlas Biotech to submit new BE protocol - Medical Dialogues

Click here to get full coverage on WINDLAS BIOTECH Share Price Today Up 19% - Equitymaster

WINDLAS BIOTECH Share Price Today Up 19%  Equitymaster

WINDLAS BIOTECH Share Price Today Up 19% - Equitymaster

Click here to get full coverage on WINDLAS BIOTECH Share Price Today Up 11% - Equitymaster

WINDLAS BIOTECH Share Price Today Up 11%  Equitymaster

WINDLAS BIOTECH Share Price Today Up 11% - Equitymaster

Click here to get full coverage on WINDLAS BIOTECH Share Price Today Down 7% - Equitymaster

WINDLAS BIOTECH Share Price Today Down 7%  Equitymaster

WINDLAS BIOTECH Share Price Today Down 7% - Equitymaster

Click here to get full coverage on This smallcap pharma stock hit 20% upper circuit today; rose 32% in a year - Business Standard

This smallcap pharma stock hit 20% upper circuit today; rose 32% in a year  Business Standard

This smallcap pharma stock hit 20% upper circuit today; rose 32% in a year - Business Standard

Click here to get full coverage on MATEON THERAPEUTICS AND WINDLAS BIOTECH ENTER INTO - GlobeNewswire

MATEON THERAPEUTICS AND WINDLAS BIOTECH ENTER INTO  GlobeNewswire

MATEON THERAPEUTICS AND WINDLAS BIOTECH ENTER INTO - GlobeNewswire

Click here to get full coverage on Shredded documents and trick cameras: FDA knocks Indian drugmaker Windlas for brazen errors - FiercePharma

Shredded documents and trick cameras: FDA knocks Indian drugmaker Windlas for brazen errors  FiercePharma

Shredded documents and trick cameras: FDA knocks Indian drugmaker Windlas for brazen errors - FiercePharma

Click here to get full coverage on Windlas Biotech commissions injectables facility in Gurugram, shares up - BusinessLine

Windlas Biotech commissions injectables facility in Gurugram, shares up  BusinessLine

Windlas Biotech commissions injectables facility in Gurugram, shares up - BusinessLine

Click here to get full coverage on WINDLAS Stock Price and Chart — NSE:WINDLAS - TradingView

WINDLAS Stock Price and Chart — NSE:WINDLAS  TradingView

WINDLAS Stock Price and Chart — NSE:WINDLAS - TradingView

Click here to get full coverage on Starlineps Enterprises Ltd leads losers in 'B' group - Business Standard

Starlineps Enterprises Ltd leads losers in 'B' group  Business Standard

Starlineps Enterprises Ltd leads losers in 'B' group - Business Standard

Click here to get full coverage on Windlas Biotech IPO subscribed 3.18 times on Day 1 - CNBCTV18

Windlas Biotech IPO subscribed 3.18 times on Day 1  CNBCTV18

Windlas Biotech IPO subscribed 3.18 times on Day 1 - CNBCTV18

Click here to get full coverage on Windlas Biotech appoints Komal Gupta as CEO - Indian Pharma Post

Windlas Biotech appoints Komal Gupta as CEO  Indian Pharma Post

Windlas Biotech appoints Komal Gupta as CEO - Indian Pharma Post

Click here to get full coverage on We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table: Hitesh Windla.. - ETHealthWorld

We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table: Hitesh Windla..  ETHealthWorld

We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table: Hitesh Windla.. - ETHealthWorld

Click here to get full coverage on Windlas Biotech IPO opens today: Here’s everything you need to know - The Indian Express

Windlas Biotech IPO opens today: Here’s everything you need to know  The Indian Express

Windlas Biotech IPO opens today: Here’s everything you need to know - The Indian Express

Click here to get full coverage on Windlas Biotech IPO to open today; here are key things to know - CNBCTV18

Windlas Biotech IPO to open today; here are key things to know  CNBCTV18

Windlas Biotech IPO to open today; here are key things to know - CNBCTV18

Click here to get full coverage on How Windlas Healthcare studied FDA rulings and tweaked systems to come up trumps at inspection - The Economic Times

How Windlas Healthcare studied FDA rulings and tweaked systems to come up trumps at inspection  The Economic Times

How Windlas Healthcare studied FDA rulings and tweaked systems to come up trumps at inspection - The Economic Times

Click here to get full coverage on GMP Evaporates on Listing Day; Windlas Biotech Makes Disappointing Debut - Outlook Business

GMP Evaporates on Listing Day; Windlas Biotech Makes Disappointing Debut  Outlook Business

GMP Evaporates on Listing Day; Windlas Biotech Makes Disappointing Debut - Outlook Business

Click here to get full coverage on Windlas Biotech Limited commissions its State-of-the-Art Injectable facility - Equity Bulls

Windlas Biotech Limited commissions its State-of-the-Art Injectable facility  Equity Bulls

Windlas Biotech Limited commissions its State-of-the-Art Injectable facility - Equity Bulls

Click here to get full coverage on Windlas Biotech Ends 11.49% Lower On Market Debut - NDTV Profit

Windlas Biotech Ends 11.49% Lower On Market Debut  NDTV Profit

Windlas Biotech Ends 11.49% Lower On Market Debut - NDTV Profit

Click here to get full coverage on Windlas Biotech IPO's weak debut: Shares list at 5% discount to issue price - Moneycontrol

Windlas Biotech IPO's weak debut: Shares list at 5% discount to issue price  Moneycontrol

Windlas Biotech IPO's weak debut: Shares list at 5% discount to issue price - Moneycontrol

Click here to get full coverage on Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma

Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform  Express Pharma

Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma

Click here to get full coverage on Windlas Biotech appoints Shailendra Rastogi as CBO - Indian Pharma Post

Windlas Biotech appoints Shailendra Rastogi as CBO  Indian Pharma Post

Windlas Biotech appoints Shailendra Rastogi as CBO - Indian Pharma Post

Click here to get full coverage on Windlas Biotech shares settle with 11.6% loss to issue price in debut trade - Moneycontrol

Windlas Biotech shares settle with 11.6% loss to issue price in debut trade  Moneycontrol

Windlas Biotech shares settle with 11.6% loss to issue price in debut trade - Moneycontrol

Click here to get full coverage on IPO-bound Windlas Biotech plans to build CDMO injectable biz, trade generics - Moneycontrol

IPO-bound Windlas Biotech plans to build CDMO injectable biz, trade generics  Moneycontrol

IPO-bound Windlas Biotech plans to build CDMO injectable biz, trade generics - Moneycontrol

Click here to get full coverage on Windlas Biotech IPO: 10 key things to know before the issue opens - Moneycontrol

Windlas Biotech IPO: 10 key things to know before the issue opens  Moneycontrol

Windlas Biotech IPO: 10 key things to know before the issue opens - Moneycontrol

Click here to get full coverage on Windlas Biotech Makes Weak Market Debut; Lists At Discount Of 5% - NDTV Profit

Windlas Biotech Makes Weak Market Debut; Lists At Discount Of 5%  NDTV Profit

Windlas Biotech Makes Weak Market Debut; Lists At Discount Of 5% - NDTV Profit

Click here to get full coverage on Windlas Biotech opens for subscription this week - Indian Pharma Post

Windlas Biotech opens for subscription this week  Indian Pharma Post

Windlas Biotech opens for subscription this week - Indian Pharma Post

Click here to get full coverage on Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - nuFFooDS Spectrum

Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal  nuFFooDS Spectrum

Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - nuFFooDS Spectrum

Click here to get full coverage on More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas Biotech - The Financial Express

More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas Biotech  The Financial Express

More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas Biotech - The Financial Express

Click here to get full coverage on Windlas Biotech IPO allotment date today. Here’s how to check application status online - Mint

Windlas Biotech IPO allotment date today. Here’s how to check application status online  Mint

Windlas Biotech IPO allotment date today. Here’s how to check application status online - Mint

Click here to get full coverage on Windlas Biotech IPO to open on Aug 4; price band set at Rs 448-460/share - Business Standard

Windlas Biotech IPO to open on Aug 4; price band set at Rs 448-460/share  Business Standard

Windlas Biotech IPO to open on Aug 4; price band set at Rs 448-460/share - Business Standard

Click here to get full coverage on Windlas Biotech IPO opens. Should you subscribe? - Times Now

Windlas Biotech IPO opens. Should you subscribe?  Times Now

Windlas Biotech IPO opens. Should you subscribe? - Times Now

Click here to get full coverage on CBI gets 1-day remand of bizman Sudhir Windlass - The Times of India

CBI gets 1-day remand of bizman Sudhir Windlass  The Times of India

CBI gets 1-day remand of bizman Sudhir Windlass - The Times of India

Click here to get full coverage on Windlas Biotech shares list at loss; debut trading at 4.6% discount to IPO price - The Financial Express

Windlas Biotech shares list at loss; debut trading at 4.6% discount to IPO price  The Financial Express

Windlas Biotech shares list at loss; debut trading at 4.6% discount to IPO price - The Financial Express

Click here to get full coverage on Windlass Biotech gets CDSCO Panel Nod To Manufacture, Market Ezetimibe plus Atorvastatin Calcium tablet - Medical Dialogues

Windlass Biotech gets CDSCO Panel Nod To Manufacture, Market Ezetimibe plus Atorvastatin Calcium tablet  Medical Dialogues

Windlas Biotech Limited (WINDLAS)

Price Chart

Key Statistics

Technicals

About WINDLAS

Latest News

Windlas Biotech Schedules Investor Meeting at Dehradun Facility - TipRanks

Windlas Biotech’s new injectable facility receives GMP certification - Indian Pharma Post

Windlas Biotech (NSE:WINDLAS) Seems To Use Debt Quite Sensibly - Simply Wall St

Advanced Charts

Top Gainers

Top Losers